Wound Management, Worldwide Market and Forecast to 2018

New Report, June 2012:

Wound Management, Worldwide Market and Forecast to 2018:  Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World.

This report will detail the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report will detail current clinical and technology developments in the worldwide market providing a current assessment of products in development and on the market; market size and forecast; competitor market shares; 75-100 competitor profiles; and an assesment of the market opportunity for current and hopeful competitors. The report will provide full year (actual) 2011 market size and share data, with forecast market data to 2018, for the Americas (with detail for U.S., Rest of North America and Latin America), Europe (with detail for United Kingdom, Germany, France, Spain, Italy, and Rest of Europe), Asia/Pacific (with detail for Japan, Korea and Rest of Asia/Pacific) and Rest of World.

This report will detail the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Emphasis will be placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) will be provided for established segments — multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report will detail the clinical and technology developments underlying the clinical practice and market development in wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report’s company profiles will assess leading and key emerging companies regarding current/projected products, technologies and positions in the advanced wound care market.  

Preliminary Table of Contents
 
EXECUTIVE SUMMARY
 
SECTION 1: BACKGROUND
 
1.1. Industry Structure
1.2. A Complex Industry
1.3. Major Wound Management Corporations
1.4. Historical Perspective and Technology Breakthroughs
1.5. Worldwide Regulatory and Reimbursement Environment
1.5.1. Cost-Effectiveness
1.5.2. Clinical
1.5.3. Regulatory
1.5.4. Major National Reimbursement Situations
1.5.4.1. United States
1.5.4.2. European Union
1.5.4.2.1. United Kingdom
1.5.4.2.2. Germany
1.5.4.2.3. France
1.5.4.2.4. Italy
1.5.4.2.5. Spain
1.5.4.2.6. Belgium
1.5.4.2.7. Scandinavia
1.5.4.3. Asia Pacific
1.5.4.3.1. Japan
1.5.4.3.2. Australia
1.6. Wound Management Trends
1.6.1. Surgical Wounds
1.6.2. Traumatic Wounds
1.6.3. Burns
1.6.4. Chronic Wounds
1.7. Market Dynamics
 
SECTION 2: CLINICAL BACKGROUND AND CASELOAD
 
2.1. Background
2.2. Skin Anatomy: A Summary
2.3. Types of Wounds
2.3.1. Classification
2.3.1.1. By Severity
2.3.1.2. By Morphology
2.3.1.3. By Etiology
2.3.1.4. Color Classification
2.3.2. Surgical Wounds
2.3.3. Traumatic Wounds
2.3.4. Burns
2.3.4.1. Debridement
2.3.4.2. Grafting
2.3.5. Ulcers
2.3.5.1. Ulcer Classification
2.3.5.2. Hospital-Acquired Ulcers
2.3.5.3. Pressure Ulcers
2.3.5.4. Venous Ulcers
2.3.5.5. Arterial Ulcers
2.3.5.6. Diabetic Ulcers
2.3.5.6.1. Prevalence
2.3.5.6.2. Stages of Diabetic Ulcer
2.3.5.6.3. Treatment
2.3.5.6.4. Amputations
2.4. Wound Healing Physiology
2.4.1. Inflammatory Phase
2.4.2. Proliferative Phase
2.4.3. Angiogenesis
2.4.4. Maturation Phase
2.5. Factors Affecting Wound Healing
2.5.1. Extrinsic Factors
2.5.1.1. Mechanical Stress
2.5.1.2. Debris
2.5.1.3. Temperature
2.5.1.4. Desiccation and Maceration
2.5.1.5. Infection
2.5.1.6. Chemical Stress
2.5.1.7. Medication
2.5.1.8. Other Extrinsic Factors
2.5.2. Intrinsic Factors
2.5.2.1. Health Status
2.5.2.2. Age Factors
2.5.2.3. Body Build
2.5.2.4. Nutritional Status
2.6. Major Treatment Categories and Regimens
2.7. Incidence of Treatments, Growth Rates and Trends
 
SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS
 
3.1. Background
3.2. Traditional Wound Care Products
3.2.1. Adhesive Bandages
3.2.2. Gauze
3.2.3. Overview
3.2.4. Product Examples
3.2.5. Market and Competitive Activity
3.3. Interactive Wound Healing Products
3.3.1. Film Dressings
3.3.1.1. Overview
3.3.1.2. Leading Products and Other Product Examples
3.3.1.3. Market and Competitive Activity
3.3.2. Foam Dressings
3.3.2.1. Overview
3.3.2.2. Leading Products and Other Product Examples
3.3.2.3. Market and Competitive Activity
3.3.3. Hydrogels
3.3.3.1. Overview
3.3.3.2. Leading Products and Other Product Examples
3.3.3.3. Market and Competitive Activity
3.4. Bioactive Wound Healing Products
3.4.1. Hydrocolloids
3.4.1.1. Overview
3.4.1.2. Leading Products and Other Product Examples
3.4.1.3. Market and Competitive Activity
3.4.2. Alginate Dressings
3.4.2.1. Overview
3.4.2.2. Leading Products and Other Product Examples
3.4.2.3. Market and Competitive Activity
3.4.3. Antimicrobial Dressings
3.4.3.1. Silver Antimicrobial Dressings
3.4.3.1.1. Overview
3.4.3.1.2. Leading Products and Other Product Examples
3.4.3.1.3. Market and Competitive Activity
3.4.3.2. Non-Silver Anti-Microbial Dressings
3.4.3.2.1. Overview
3.4.3.2.2. Leading Products and Other Product Examples
3.4.3.2.3. Market and Competitive Activity
3.5. Biologics
3.5.1. Overview
3.5.1.1. Skin Replacements
3.5.1.2. Collagen Based Dressings
3.5.1.3. Gene Therapy
3.5.2. Leading Products and Other Product Examples
3.5.3. Market and Competitive Activity
3.6. Wound Care Devices
3.6.1. Negative Pressure Devices
3.6.1.1. Overview
3.6.1.2. Leading Products and Other Product Examples
3.6.1.3. Market and Competitive Activity
3.6.2. Ultrasound Devices
3.6.2.1. Overview
3.6.2.2. Leading Products and Other Product Examples
3.6.2.3. Market and Competitive Activity
3.6.3. Electrical Stimulation Devices
3.6.3.1. Overview
3.6.3.2. Leading Products and Other Product Examples
3.6.3.3. Market and Competitive Activity
3.6.4. Other Physical Wound Therapies
3.6.4.1. Hydrotherapy
3.6.4.2. Ultraviolet Therapy
3.6.4.3. Hyperbaric Oxygen Therapy
3.6.4.4. Laser Devices
3.6.4.5. Pressure Relief Devices
3.6.4.6. Leading Products and Other Product Examples
3.7. Pharmacological Products
3.7.1. Overview
3.7.2. Leading Products and Other Product Examples
3.7.2.1. Growth Factors
3.7.2.1.1. Growth Factors: Background
3.7.2.1.2. Classification
3.7.2.2. Other Growth Factors
3.7.2.3. Non-Growth Factor Modulators
3.7.3. Market and Competitive Activity
3.8. Alternative Wound Therapies
3.8.1. Maggot Therapy
3.8.2. Leech Therapy
3.8.3. Ichthyotherapy
3.9. Product Categories Covered in This Report
3.9.1. Traditional Wound Care Products
3.9.2. Film Dressings
3.9.3. Foam Dressings
3.9.4. Hydrogels
3.9.5. Hydrocolloids
3.9.6. Alginate Dressings
3.9.7. Silver Antimicrobial Dressings
3.9.8. Negative Pressure Wound Therapy Devices
 
SECTION 4: COUNTRY MARKET FORECAST 2012-2018 AND COMPETITOR 
MARKET SHARES (2011) BY PRODUCT SEGMENT/COUNTRY
 
4.1. Global Overview
4.2. Market Estimates
4.3. Market Potential
4.4. Leading Wound Care Companies
4.5. Americas
4.5.1. United States
4.5.2. Rest of North America
4.5.3. Latin America
4.6. European Union
4.6.1. United Kingdom
4.6.2. Germany
4.6.3. France
4.6.4. Italy
4.6.5. Spain
4.6.6. Rest of Europe
4.7. Asia/Pacific
4.7.1. Japan
4.7.2. Korea
4.7.3. Rest of Asia/Pacific
4.8. Rest of World
 
SECTION 5: COMPANY PROFILES (preliminary list)
 
5.1. Major Companies
5.1.1. 3M Health Care
5.1.2. B. Braun Melsungen AG
5.1.3. Coloplast Group
5.1.4. ConvaTec Inc.
5.1.5. Covidien
5.1.6. Kendall
5.1.7. Derma Sciences, Inc
5.1.8. DeRoyal Industries Inc.
5.1.9. Ethicon (Johnson & Johnson)
5.1.10. Gentell Inc
5.1.11. Geritrex Corp.
5.1.12. Hartmann Group
5.1.13. Hollister Incorporated
5.1.14. Lohmann & Rauscher International GmbH and Co. KG
5.1.15. Medline Industries
5.1.16. Mölnlycke Health Care AB
5.1.17. Smith & Nephew plc
5.1.18. Systagenix Wound Management (US), Inc.
5.1.19. UDL Laboratories
5.2. Specialist Companies
5.2.1. Antimicrobial Dressings
5.2.1.1. AcryMed Inc.
5.2.1.2. Argentum Products LLC
5.2.1.3. Microban International Ltd.
5.2.2. Oxygen Therapy
5.2.2.1. Perry Baromedical
5.2.3. Tissue Regeneration
5.2.3.1. Perry Baromedical
5.2.3.2. Celltran Limited
5.2.3.3. Euroderm AG
5.2.3.4. Fidia Advanced Biopolymers
5.2.3.5. Forticell Bioscience, Inc.
5.2.3.6. Genzyme Biosurgery (Sanofi-Aventis)
5.2.3.7. Integra LifeSciences Inc.
5.2.3.8. Organogenesis Inc
5.2.3.9. Kinetic Concepts Inc
5.2.3.10. LifeCell Corporation
5.2.4. Growth Factors
5.2.4.1. ES Cell International
5.2.5. Electrical Therapies
5.2.5.1. BioMedical Life Systems, Inc
5.2.5.2. Diapulse Corporation of America
5.2.5.3. Electromedical Products International Inc
5.2.5.4. Koldcare
5.2.5.5. MicroVas Technologies, Inc
5.2.6. Odor Control
5.2.6.1. CliniMed Limited
5.2.7. Other Therapeutic Modalities
5.2.7.1. AGT Sciences Ltd
5.2.7.2. Agennix Incorporated

For advance ordering, purchase online or fax your order form.

 


See also, "Surgical Sealants, Glues, Wound Closure and Anti-Adhesion, Worldwide Markets, 2012-2017". See details. Order online or by order form.

 

Leave a Reply